do i need parp inhibitors to treat my breast cancer? what to expect, eligibility, and side effects
Published 2 years ago • 1.1K plays • Length 6:22Download video MP4
Download video MP3
Similar videos
-
0:24
fda recommendations #short
-
0:17
bone modifying agents #short
-
3:31
distinguishing between parp inhibitors in breast cancer
-
3:58
brca breast cancer: the advent of parp inhibitors
-
5:28
benefit of parp inhibitors in brca breast cancer
-
1:27
dr. litton on the impact of parp inhibitors in breast cancer
-
7:42
parp inhibitors in other subtypes of breast cancer
-
4:02
talking with patients about parp inhibitors for breast cancer
-
3:46
case 4: parp inhibitors for treating brca triple-negative breast cancer
-
3:47
parp inhibitory velaparib trialled in brca1/2 breast cancer
-
2:38
seminar clips: parp inhibitors and brrca1/2 cancers- susan domchek, md | stanford cancer institute
-
0:45
parp inhibitors versus standard of care treatment in breast cancer
-
4:59
future role of parp inhibition in brca breast cancer
-
1:13:00
expanding the benefits of parp inhibitors to more patients with breast cancer and earlier settings
-
27:25
opportunities and challenges in early breast cancer: do parp inhibitors have a role?
-
4:19
treating brca breast cancer with parp inhibition
-
1:16
parp inhibitors improve outcomes, qol in breast cancer
-
2:59
parp inhibitors for metastatic breast cancer
-
4:11
brca breast cancer: managing patients on parp inhibitors